|
- Treatment and Recovery | National Institute on Drug Abuse
Certain treatment medications and devices reduce these symptoms, which makes it easier to stop the drug use Staying in treatment Some treatment medications and mobile applications are used to help the brain adapt gradually to the absence of the drug These treatments act slowly to help prevent drug cravings and have a calming effect on body
- Treatment - National Institute on Drug Abuse (NIDA)
For example, treatment with methadone, buprenorphine, or naltrexone is standard of care for opioid use disorder The medication lofexidine is approved for treatment of opioid withdrawal symptoms Medications are also available for the treatment of alcohol use disorder and to help people quit smoking Depending on the type of medication, it may:
- Principles of Drug Addiction Treatment: A Research-Based Guide (Third . . .
To be effective, treatment must address the individual’s drug abuse and any associated medical, psychological, social, vocational, and legal problems It is also important that treatment be appropriate to the individual’s age, gender, ethnicity, and culture 5 Remaining in treatment for an adequate period of time is critical
- principles of drug addiction treatment - National Institute on Drug . . .
3 Treatment needs to be readily available Because drug-addicted individuals may be uncertain about entering treatment, taking advantage of available services the moment people are ready for treatment is critical Potential patients can be lost if treatment is not immediately available or readily accessible As with
- Advancing reduction of drug use as an endpoint in addiction treatment . . .
It can pose a barrier to seeking and entering treatment and perpetuate stigma and shame at treatment setbacks By the same token, reduction of substance use has important public health benefits as well as clinical benefits for patients, and recognition of this could greatly advance medication development for treatment of addiction and its symptoms
- What are treatments for tobacco dependence? | National Institute on . . .
The prevalence of tobacco use and dependence among adolescents—as well as the neurobiological impact and medical consequences of nicotine exposure—suggest that pediatric primary care settings should deliver tobacco cessation treatments to both youth and parents who use tobacco 169 Current clinical guidance does not recommend medications for adolescent tobacco cessation because of a lack
- Methamphetamine | National Institute on Drug Abuse (NIDA)
Methamphetamine is a powerful lab-made (synthetic) stimulant with high addiction potential 1 The U S Food and Drug Administration (FDA) has approved methamphetamine for treatment of attention deficit hyperactivity disorder (ADHD) as well as for short-term treatment of obesity It is classified by the U S Drug Enforcement Administration (DEA
- Medications for Opioid Use Disorder | National Institute on Drug Abuse
Stigma associated with substance use disorder treatment—both toward people in recovery and or by their health care providers—may limit access to these medications 30; People from racial and ethnic minoritized groups may face more barriers to medication treatment for opioid use disorder than White individuals 31, 32
|
|
|